A detailed history of Mediolanum International Funds LTD transactions in United Therapeutics Corp stock. As of the latest transaction made, Mediolanum International Funds LTD holds 4,804 shares of UTHR stock, worth $1.74 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,804
Previous 4,492 6.95%
Holding current value
$1.74 Million
Previous $1.33 Billion 29.38%
% of portfolio
0.02%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$311.04 - $363.55 $97,044 - $113,427
312 Added 6.95%
4,804 $1.72 Billion
Q2 2024

Aug 13, 2024

SELL
$228.26 - $319.04 $155,901 - $217,904
-683 Reduced 13.2%
4,492 $1.33 Billion
Q1 2024

May 03, 2024

BUY
$210.76 - $249.51 $1.09 Million - $1.29 Million
5,175 New
5,175 $1.26 Billion

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Mediolanum International Funds LTD Portfolio

Follow Mediolanum International Funds LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mediolanum International Funds LTD, based on Form 13F filings with the SEC.

News

Stay updated on Mediolanum International Funds LTD with notifications on news.